Clinical trials
Completed Neutropenia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
192 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 6 |
| 2001 | 4 |
| 2002 | 10 |
| 2003 | 10 |
| 2004 | 5 |
| 2005 | 3 |
| 2006 | 7 |
| 2007 | 6 |
| 2008 | 9 |
| 2009 | 4 |
| 2010 | 11 |
| 2011 | 10 |
| 2012 | 15 |
| 2013 | 7 |
| 2014 | 6 |
| 2015 | 15 |
| 2016 | 7 |
| 2017 | 8 |
| 2018 | 6 |
| 2019 | 6 |
| 2020 | 6 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 192 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 14 |
| National Heart, Lung, and Blood Institute (NHLBI) | 12 |
| National Cancer Institute (NCI) | 8 |
| EVIVE Biotechnology | 7 |
| Pfizer | 7 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 5 |
| Sandoz | 5 |
| Children's Oncology Group | 4 |
| Merck Sharp & Dohme LLC | 4 |
| Spectrum Pharmaceuticals, Inc | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neutropenia | 192 |
| Breast Neoplasms | 34 |
| Fever | 30 |
| Neoplasms | 26 |
| Febrile Neutropenia | 23 |
| Infections | 21 |
| Thrombocytopenia | 21 |
| Leukemia | 16 |
| Leukemia, Myeloid, Acute | 15 |
| Hematologic Neoplasms | 13 |
Trials
Showing 1 to 25 of 192. Each trial links to its page on Pharma Observatory.
92 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.